All U.S. Briefs cbd FDA Commissioner Robert Califf hemp CBD Hemp Industry News Legal marijuana rescheduling Medical & Recreational recreational retail U.S. Drug Enforcement Administration U.S. Food and Drug Administration U.S. Rep. James Comer

‘No reason’ for DEA to delay marijuana rescheduling, FDA chief says

There’s “no reason” for the U.S. Drug Enforcement Administration to delay its long-awaited decision on moving marijuana from Schedule 1 to Schedule 3 of the Controlled Substances Act, the head of the Food and Drug Administration told a House committee….